Literature DB >> 21387163

Neuronal hyperexcitability: a substrate for central neuropathic pain after spinal cord injury.

Young Seob Gwak1, Claire E Hulsebosch.   

Abstract

Neuronal hyperexcitability produces enhanced pain transmission in the spinal dorsal horn after spinal cord injury (SCI). Spontaneous and evoked neuronal excitability normally are well controlled by neural circuits. However, SCI produces maladaptive synaptic circuits in the spinal dorsal horn that result in neuronal hyperexcitability. After SCI, activated primary afferent neurons produce enhanced release of glutamate, neuropeptides, adenosine triphosphate, and proinflammatory cytokines, which are known to be major components for pain transmission in the spinal dorsal horn. Enhanced neurochemical events contribute to neuronal hyperexcitability, and neuroanatomical changes also contribute to maladaptive synaptic circuits and neuronal hyperexcitability. These neurochemical and neuroanatomical changes produce enhanced cellular signaling cascades that ensure persistently enhanced pain transmission. This review describes altered neurochemical and neuroanatomical contributions on neuronal hyperexcitability in the spinal dorsal horn, which serve as substrates for central neuropathic pain after SCI. © Springer Science+Business Media, LLC 2011

Entities:  

Mesh:

Year:  2011        PMID: 21387163     DOI: 10.1007/s11916-011-0186-2

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  48 in total

1.  Transplantation of GABAergic neurons from ESCs attenuates tactile hypersensitivity following spinal cord injury.

Authors:  Dae-Sung Kim; Se Jung Jung; Taick Sang Nam; Young Hoon Jeon; Dongjin R Lee; Jae Souk Lee; Joong Woo Leem; Dong-Wook Kim
Journal:  Stem Cells       Date:  2010-11       Impact factor: 6.277

2.  Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats.

Authors:  Megan Ryan Detloff; Lesley C Fisher; Violetta McGaughy; Erin E Longbrake; Phillip G Popovich; D Michele Basso
Journal:  Exp Neurol       Date:  2008-04-20       Impact factor: 5.330

3.  Group I metabotropic glutamate receptors in spinal cord injury: roles in neuroprotection and the development of chronic central pain.

Authors:  Charles D Mills; Kathia M Johnson; Claire E Hulsebosch
Journal:  J Neurotrauma       Date:  2002-01       Impact factor: 5.269

4.  Excitotoxic spinal cord injury: behavioral and morphological characteristics of a central pain model.

Authors:  P R Yezierski; S Liu; L G Ruenes; J K Kajander; L K Brewer
Journal:  Pain       Date:  1998-03       Impact factor: 6.961

5.  Serotonergic neural precursor cell grafts attenuate bilateral hyperexcitability of dorsal horn neurons after spinal hemisection in rat.

Authors:  B C Hains; K M Johnson; M J Eaton; W D Willis; C E Hulsebosch
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

6.  Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2.

Authors:  P S Fidler; K Schuette; R A Asher; A Dobbertin; S R Thornton; Y Calle-Patino; E Muir; J M Levine; H M Geller; J H Rogers; A Faissner; J W Fawcett
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

7.  Propentofylline attenuates allodynia, glial activation and modulates GABAergic tone after spinal cord injury in the rat.

Authors:  Young Seob Gwak; Eric D Crown; Geda C Unabia; Claire E Hulsebosch
Journal:  Pain       Date:  2008-03-18       Impact factor: 6.961

8.  Nuclear factor-kappaB decoy amelioration of spinal cord injury-induced inflammation and behavior outcomes.

Authors:  Danny Salah Rafati; Katja Geissler; Kathia Johnson; Geda Unabia; Claire Hulsebosch; Olivera Nesic-Taylor; J Regino Perez-Polo
Journal:  J Neurosci Res       Date:  2008-02-15       Impact factor: 4.164

Review 9.  Neuropathic pain: a clinical perspective.

Authors:  Ralf Baron
Journal:  Handb Exp Pharmacol       Date:  2009

10.  Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury.

Authors:  Susan M Carlton; Junhui Du; Huai Yu Tan; Olivera Nesic; Gregory L Hargett; Anne C Bopp; Ammar Yamani; Qing Lin; William D Willis; Claire E Hulsebosch
Journal:  Pain       Date:  2009-10-22       Impact factor: 6.961

View more
  35 in total

1.  Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Brain Res       Date:  2011-07-26       Impact factor: 3.252

Review 2.  Spinal Cord Stimulation for Pain Treatment After Spinal Cord Injury.

Authors:  Qian Huang; Wanru Duan; Eellan Sivanesan; Shuguang Liu; Fei Yang; Zhiyong Chen; Neil C Ford; Xueming Chen; Yun Guan
Journal:  Neurosci Bull       Date:  2018-12-17       Impact factor: 5.203

3.  Combinations of intrathecal gamma-amino-butyrate receptor agonists and N-methyl-d-aspartate receptor antagonists in rats with neuropathic spinal cord injury pain.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Eur J Pharmacol       Date:  2012-03-16       Impact factor: 4.432

Review 4.  Spinal cord injury pain: mechanisms and management.

Authors:  Nanna Brix Finnerup; Cathrine Baastrup
Journal:  Curr Pain Headache Rep       Date:  2012-06

Review 5.  How is chronic pain related to sympathetic dysfunction and autonomic dysreflexia following spinal cord injury?

Authors:  Edgar T Walters
Journal:  Auton Neurosci       Date:  2017-01-27       Impact factor: 3.145

6.  Ablation of IB4 non-peptidergic afferents in the rat facet joint prevents injury-induced pain and thalamic hyperexcitability via supraspinal glutamate transporters.

Authors:  Christine L Weisshaar; Jeffrey V Kras; Parul S Pall; Sonia Kartha; Beth A Winkelstein
Journal:  Neurosci Lett       Date:  2017-07-06       Impact factor: 3.046

7.  Decreased spinothalamic and dorsal column medial lemniscus-mediated function is associated with neuropathic pain after spinal cord injury.

Authors:  Yenisel Cruz-Almeida; Elizabeth R Felix; Alberto Martinez-Arizala; Eva G Widerström-Noga
Journal:  J Neurotrauma       Date:  2012-08-27       Impact factor: 5.269

8.  Overexpression of the astrocyte glutamate transporter GLT1 exacerbates phrenic motor neuron degeneration, diaphragm compromise, and forelimb motor dysfunction following cervical contusion spinal cord injury.

Authors:  Ke Li; Charles Nicaise; Daniel Sannie; Tamara J Hala; Elham Javed; Jessica L Parker; Rajarshi Putatunda; Kathleen A Regan; Valérie Suain; Jean-Pierre Brion; Fred Rhoderick; Megan C Wright; David J Poulsen; Angelo C Lepore
Journal:  J Neurosci       Date:  2014-05-28       Impact factor: 6.167

Review 9.  Opioid administration following spinal cord injury: implications for pain and locomotor recovery.

Authors:  Sarah A Woller; Michelle A Hook
Journal:  Exp Neurol       Date:  2013-03-15       Impact factor: 5.330

10.  Increased Levels of Circulating Glial Fibrillary Acidic Protein and Collapsin Response Mediator Protein-2 Autoantibodies in the Acute Stage of Spinal Cord Injury Predict the Subsequent Development of Neuropathic Pain.

Authors:  Georgene W Hergenroeder; John B Redell; H Alex Choi; Lisa Schmitt; William Donovan; Gerard E Francisco; Karl Schmitt; Anthony N Moore; Pramod K Dash
Journal:  J Neurotrauma       Date:  2018-07-05       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.